G beta gamma directly binds to the carboxyl terminus of the G protein-gated muscarinic K+ channel, GIRK1. 1995

A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
Department of Cell Biology and Signaling, Yamagata University School of Medicine, Japan.

beta gamma Subunits of heterotrimeric GTP-binding proteins (G beta gamma) activate the inwardly rectifying muscarinic K+ channel, GIRK1. The significant role for the carboxyl (C) terminus of GIRK1 in this interaction has been suggested. However, it is still unknown whether G beta gamma directly interacts with GIRK1. To elucidate the molecular basis of G beta gamma-activation of GIRK1, we examined the binding properties of G beta gamma to the C terminus of GIRK1 cloned from mouse brain cDNA library (MB-GIRK1). The C terminus of MB-GIRK1 fused with glutathione S-transferase directly bound to purified G beta gamma. Incubation of the C terminus with Gi pretreated with GTP gamma S, but not with GDP, resulted in the binding of Gi beta gamma to the protein. Purified G alpha-GDP, but not G alpha-GTP gamma S, inhibited the binding of G beta gamma to the fusion protein. These results indicate that G beta gamma dissociated from G alpha may directly bind to the C terminus of GIRK1.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D015221 Potassium Channels Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits. Ion Channels, Potassium,Ion Channel, Potassium,Potassium Channel,Potassium Ion Channels,Channel, Potassium,Channel, Potassium Ion,Channels, Potassium,Channels, Potassium Ion,Potassium Ion Channel

Related Publications

A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
December 1995, The Journal of biological chemistry,
A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
November 1995, Neuron,
A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
March 1994, Nature,
A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
September 1994, Neuron,
A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
February 1989, Nature,
A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
August 1998, The Journal of general physiology,
A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
February 2001, Journal of molecular neuroscience : MN,
A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
June 1988, The American journal of physiology,
A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
January 1996, Neuropharmacology,
A Inanobe, and K I Morishige, and N Takahashi, and H Ito, and M Yamada, and T Takumi, and H Nishina, and K Takahashi, and Y Kanaho, and T Katada
July 2009, The Journal of physiology,
Copied contents to your clipboard!